Benefits from Disease-Burden Reduction for Type 2 Diabetes and Obesity Through Comprehensive Regulatory Restrictions on Phthalate Use in China

Shanshan Shi,Junfeng (Jim) Zhang,Jicheng Gong,Bin Zhao
DOI: https://doi.org/10.1016/j.oneear.2022.03.013
IF: 14.944
2022-01-01
One Earth
Abstract:SCIENCE FOR SOCIETY Phthalates, a group of chemicals used to make plastics more durable, are used in a wide variety of household and personal products and have been associated with numerous metabolic disorders, including diabetes and obesity. In China, the world's largest market of phthalates, comprehensive restrictions are limited, and the associated public-health burden is significant. This work investigates the potential type-2 -diabetes-and obesity-related public-health savings that would result from introducing restrictions on the use of five widely used phthalates. Under the most severe restriction scenario, phthalate use and exposure could almost be eliminated by 2031 (relative to 2016) with an estimated public-health savings of 134.6 billion CNY.
What problem does this paper attempt to address?